Last updated 2026-06-18
- Raised $1M funding round led by NGT HealthCare II, Jan 2022
Total raised
$1.0M
Last: 2022-01
Stage
Pre-Seed
Founded
2021
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
SLATE Therapeutics is dedicated to revolutionizing the treatment of chronic rhinosinusitis (CRS) with SilexGel, a novel sol-gel hydrogel technology.
Its mission is to improve patients' quality of life through innovative and effective treatments. SilexGel is a cutting-edge platform technology designed for the systemic and localized delivery of therapeutics. Unlike drug-eluting implants that tend to migrate and cause side effects, or nasal sprays that offer short-term relief, SilexGel provides long-lasting effects with minimal side effects.
Funding history · 1 round · $1.0M total
2022-01
Q&A
- What is Slate Therapeutics' primary focus?
- Slate Therapeutics is dedicated to revolutionizing the treatment of chronic rhinosinusitis (CRS) with SilexGel, a novel sol-gel hydrogel technology.
- When was Slate Therapeutics founded?
- Slate Therapeutics was founded in April 2021.
- How much funding has Slate Therapeutics raised to date?
- Slate Therapeutics has raised a total of $1,000,000 USD.
- Which investors participated in Slate Therapeutics' last funding round?
- In January 2022, Slate Therapeutics raised $1,000,000 USD from NGT HealthCare II and Israel Innovation Authority.
- What is the current employee count for Slate Therapeutics?
- Slate Therapeutics has 6 employees, falling within the 1-10 employee bucket.
- Who are the co-founders of Slate Therapeutics?
- The co-founders of Slate Therapeutics include Dr. Eitan, Gary Binyamin, Tanhum Feld, and Eran Vickus.
- What is SilexGel?
- SilexGel is a cutting-edge platform technology developed by Slate Therapeutics for the systemic and localized delivery of therapeutics, designed to provide long-lasting effects with minimal side effects for conditions like chronic rhinosinusitis (CRS).
- What is Slate Therapeutics' current product stage?
- Slate Therapeutics' product is currently in the beta stage.
Team · 4
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryDrugs Discovery & Development
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcarePatients
Business model
B2B2C
Highlights
Verified
Tags
drug-deliveryhealthcaremedical-devicestreatmentsoral-drugs
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | slatetherapeutics.com/ |
|---|---|
| linkedin.com/company/82163710 |
Identifiers & details
| Founded | 2021-4 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | slatetherapeutics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|